Cargando…
Impact of hyperprolactinemia in a patient with polyautoimmunity
Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient's symptoms were associated with slightly...
Autores principales: | Rojas, Manuel, Rodríguez, Yhojan, Ramírez‐Santana, Carolina, Anaya, Juan‐Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333117/ https://www.ncbi.nlm.nih.gov/pubmed/30656000 http://dx.doi.org/10.1002/ccr3.1900 |
Ejemplares similares
-
Introducing Polyautoimmunity: Secondary Autoimmune Diseases No Longer Exist
por: Rojas-Villarraga, Adriana, et al.
Publicado: (2012) -
The Autoimmune Tautology: From Polyautoimmunity and Familial Autoimmunity to the Autoimmune Genes
por: Anaya, Juan-Manuel, et al.
Publicado: (2012) -
Familial Aggregation and Segregation Analysis in Families Presenting Autoimmunity, Polyautoimmunity, and Multiple Autoimmune Syndrome
por: Castiblanco, John, et al.
Publicado: (2015) -
Cholangiopathy as part of post-COVID syndrome
por: Rojas, Manuel, et al.
Publicado: (2021) -
COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature
por: Camacho-Domínguez, Laura, et al.
Publicado: (2022)